Effect of toyocamycin on oncornaviral production by acutely infected cells.
The adenosine analogue toyocamycin incorporates into the RNA species of mammalia cells and abolishes at low concentrations of the processing of 45S preribosomal nucleolar RNA into the mature 28 and 18S cytoplasmic ribosomal RNAs. We have previously shown that toyocamycin depresses the production of the Friend leukemia viral complex by chronically infected cells. In this article, we report the study of the action of the drug on viral RNA in acutely infected cells. We found that, although abolishing viral production, the incorporation of toyocamycin does not inhibit the formation of mature viral messenger RNAs nor prevent the synthesis of specific viral proteins. These results are obtained at concentrations of analogue sufficient to abolish the appearance of mature cytoplasmic ribosomal RNA.
D000818:Animals; D002472:Cell Transformation, Viral / Q000187:drug effects*; D005622:Friend murine leukemia virus; D007942:Leukemia, Experimental / Q000378:metabolism*; D051379:Mice; D009693:Nucleic Acid Hybridization; D014176:Protein Biosynthesis / Q000187:drug effects; D012367:RNA, Viral / Q000378:metabolism*; D012263:Ribonucleosides / Q000494:pharmacology*; D014127:Toyocamycin / Q000494:pharmacology*; D014764:Viral Proteins / Q000032:analysis
D012367:RNA, Viral; D012263:Ribonucleosides; D014764:Viral Proteins; D014127:Toyocamycin